Growth Metrics

Beyond Air (XAIR) Amortization - Deferred Charges (2016 - 2017)

Beyond Air recorded quarterly Amortization - Deferred Charges of -$727.0 in Q4 2017, up 99.93% quarter-over-quarter from -$1.0 million in Q2 2017, and down 118.18% year-over-year from $4000.0 in Q4 2016.

Beyond Air's Amortization - Deferred Charges history runs 2 years deep, the most recent figure standing at -$727.0 for Q4 2017.

  • In Q4 2017, Amortization - Deferred Charges fell 118.18% year-over-year to -$727.0; the TTM figure through Dec 2017 stood at $14273.0 (down 10.79% YoY), while the FY2017 annual figure was $14273.0, down 10.79% from the prior year.
  • Amortization - Deferred Charges came in at -$727.0 for Q4 2017 at Beyond Air, up from -$1.0 million in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $1.0 million in Q1 2017 to a low of -$1.0 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortization - Deferred Charges (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Beyond Air 3.27 Mn -6.59 Mn 300,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 -727.00
Dec 31, 2017 -727.00
Jun 30, 2017 -1.03 Mn
Jun 30, 2017 -1.03 Mn
Mar 31, 2017 1.05 Mn
Mar 31, 2017 1.05 Mn
Dec 31, 2016 4,000.00
Dec 31, 2016 4,000.00
Sep 30, 2016 4,000.00
Sep 30, 2016 4,000.00
Jun 30, 2016 4,000.00
Jun 30, 2016 4,000.00
Mar 31, 2016 4,000.00
Mar 31, 2016 4,000.00